Merck Czech Republic made a net profit of CZK CZK 68.6 mil under revenues of CZK 1,850 mil in 2015, up 96.7% and 2.88%, respectively, when compared to the last year.
This translates into a net margin of 3.71%. Historically, the firm’s net margin reached an all time high of 9.68% in 2006 and an all time low of 0.160% in 2008. The average net margin in the last five years amounted to 2.78%.
On the operating level, EBITDA margin reached 5.12% and EBIT amounted to 5.18% of sales in 2015.
As far as Merck Czech Republic's peers are concerned, Roche Czech Republic posted net and EBITDA margin of 0.936% and 3.84%, respectively in 2015, Bayer Czech Republic generated margins of 2.89% and 3.93% and Amgen Czech Republic's profit margin reached 5.93% on the net and 7.66% on the EBITDA level in 2015.